Three and Four-Dimensional Visualization and Analysis Approaches to Study Vertebrate Axial Elongation and Segmentation
February 28th, 2021
Here, we describe computational tools and methods that allow visualization and analysis of three and four-dimensional image data of mouse embryos in the context of axial elongation and segmentation, obtained by in toto optical projection tomography, and by live imaging and whole-mount immunofluorescence staining using multiphoton microscopy.
Overview
This article presents detailed protocols for 3D and 4D imaging, visualization, and analysis of mouse embryos during axial extension and somitogenesis. By leveraging advanced imaging techniques such as optical projection tomography (OPT) and whole-mount immunofluorescence microscopy, the study enables dynamic and comprehensive examination of embryonic structures and developmental processes. The protocols facilitate both research and teaching by providing step-by-step guidance for sample preparation, imaging, and data processing, as well as highlighting software tools for 3D reconstruction and analysis.
Key Study Components
Area of Science
- Developmental biology
- Embryology
- Imaging and microscopy
Background
- Somitogenesis and axial extension are critical processes in vertebrate embryonic development.
- Traditional studies often rely on 2D imaging, which limits understanding of complex 3D developmental dynamics.
- Congenital malformations such as scoliosis can be better studied with advanced imaging techniques.
- 3D and 4D imaging approaches provide more accurate visualization and analysis of embryonic structures.
Purpose of Study
- To describe and demonstrate protocols for 3D and 4D imaging of mouse embryos during key developmental stages.
- To enable detailed visualization and analysis of neuromesodermal progenitors and other cell populations involved in axial extension and segmentation.
- To provide tools and workflows for both research and educational purposes.
Methods Used
- Dissection and preparation of mouse embryos at various developmental stages (E8.25–E18.5).
- Live imaging in controlled culture conditions for dynamic analysis.
- Whole-mount immunofluorescence staining and tissue clearing using RapiClear, methyl salicylate, or BABB.
- Optical projection tomography (OPT) for 3D imaging of cleared embryos.
- Data processing and 3D reconstruction using software such as Fiji/ImageJ, Drishti, Amira, and Imaris.
Main Results
- Protocols enable faithful 3D and 4D visualization of mouse embryonic structures and developmental processes.
- Dynamic imaging reveals differences in gene expression patterns, such as LuVeLu reporter activity in wild-type and mutant embryos.
- 3D reconstructions facilitate identification and localization of neuromesodermal progenitors and morphological defects.
- Interactive and animated 3D models can be generated for research analysis and educational outreach.
Conclusions
- 3D and 4D imaging techniques significantly enhance the study of vertebrate embryonic development.
- The described protocols and software tools improve accuracy and depth of developmental analysis.
- These methods support both advanced research and effective teaching of complex embryological processes.
Frequently Asked Questions
Executive Industry Relevance
Three- and four-dimensional imaging of vertebrate embryonic development enables unprecedented insight into dynamic morphogenetic processes, supporting higher predictive confidence in early discovery and target validation. These advanced visualization techniques facilitate mechanistic de-risking and quantitative assessment of developmental phenotypes, directly impacting preclinical model selection and translational continuity. Integrating 3D/4D imaging into R&D pipelines enhances the fidelity of disease-relevant system modeling and informs risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of developmental pathways and cellular dynamics in vertebrate models.
- Supports functional target validation by visualizing neuromesodermal progenitor behavior in situ.
- Improves predictive confidence for mechanistic hypotheses underlying congenital malformations.
- Facilitates portfolio triage by clarifying biological relevance of candidate targets.
Screening & Assay Development
- Prepares validated 3D biological systems for downstream phenotypic screening workflows.
- Standardizes imaging outputs for reproducibility and quantitative comparison across conditions.
- Enables scalable assay development through robust 3D reconstruction and analysis pipelines.
- Supports reliable evaluation of compound effects on complex tissue morphogenesis.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant developmental phenotypes, such as spinal defects.
- Ensures continuity from discovery imaging to preclinical validation of morphological endpoints.
- De-risks translational advancement by providing high-resolution, quantitative tissue characterization.
- Facilitates biomarker identification through spatially resolved 3D data.
Pipeline & Workflow Integration
3D and 4D imaging methods position discovery teams to bridge early hypothesis testing with preclinical model validation, supporting workflows from target identification through translational research.
- Discovery Biology: Provides quantitative visualization for hypothesis testing and pathway clarification in vertebrate development.
- Screening: Delivers standardized, reproducible 3D imaging outputs for assay readiness and comparative analytics.
- Analytics: Enables extraction of quantitative morphological and spatial data for robust statistical analysis.
- Translational Research: Connects imaging outputs to preclinical endpoints and disease-relevant phenotypes.
- Enterprise Reuse: Establishes a reusable imaging and analysis pipeline adaptable across developmental and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in developmental biology studies.
- Operational Value: Standardizes imaging protocols and data processing for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by clarifying biological risk early.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of disease-relevant models and targets.
Implementation Considerations
- Requires expertise in advanced imaging, tissue clearing, and 3D data analysis.
- Demands access to optical projection tomography, confocal microscopy, and compatible software platforms.
- Necessitates cross-team standardization of imaging protocols and data formats.
- Adaptable to both in vivo and in vitro model systems with protocol modifications.
- Dataset size and computational requirements may limit throughput for large-scale studies.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:04
Sample Preparation for Live Imaging
1:57
Sample Preparation for Immunofluorescence Microscopy
4:20
Repositioning of Embryo to an Anatomically Standard Position Using Fiji/ImageJ
7:19
Sample Preparation for Optical Projection Tomography
10:29
Results: Visualization and Analysis of Three and Four-Dimensional Image Data of Mouse Embryos
12:23
Conclusion
